Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
10.34
+0.01 (0.10%)
At close: Dec 5, 2025, 4:00 PM EST
10.37
+0.03 (0.29%)
After-hours: Dec 5, 2025, 5:31 PM EST

DMAA Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024
Period Ending
Sep '25 Dec '24
Selling, General & Admin
1.010.48
Operating Expenses
1.010.48
Operating Income
-1.01-0.48
Pretax Income
5.45-0.48
Net Income
5.45-0.48
Net Income to Common
5.45-0.48
Shares Outstanding (Basic)
259
Shares Outstanding (Diluted)
259
EPS (Basic)
0.22-0.06
EPS (Diluted)
0.21-0.06
EBIT
-1.01-0.48
Source: S&P Capital IQ. Standard template. Financial Sources.